Heres what the evidence currently suggests: Animal studies report mixed findings, some suggesting potential bone-protective effects, though human data is more limited
Some patients may experience taste changes that go unreported unless specifically asked, or they may attribute the symptom to other causes
Drugmakers are now chasing injectables and pills, offering people more options to combat obesity, whichever is less of a hassle
Cuccurazzu B, et al
This guide covers everything researchers need to know about alternating between these two GLP-1 receptor agonists, including the science behind why some people consider it, the practical challenges involved, dose conversion protocols , safety considerations, and alternative strategies for those who have hit a plateau
doi: 10.1038/s41598-019-40354-7 100 GotsmanIMuszkatM